{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:19:32Z","timestamp":1781932772775,"version":"3.54.5"},"reference-count":41,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1999,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>To investigate the occurrence of multinucleoside analog resistance during therapy failure, we surveyed the drug susceptibilities and genotypes of nearly 900 human immunodeficiency virus type 1 (HIV-1) samples. For 302 of these, the 50% inhibitory concentrations of at least four of the approved nucleoside analogs had fourfold-or-greater increases. Genotypic analysis of the reverse transcriptase (RT)-coding regions from these samples revealed complex mutational patterns, including the previously recognized codon 151 multidrug resistance cluster. Surprisingly, high-level multinucleoside resistance was associated with a diverse family of amino acid insertions in addition to \u201cconventional\u201d point mutations. These insertions were found between RT codons 67 and 70 and were commonly 69Ser-(Ser-Ser) or 69Ser-(Ser-Gly). Treatment history information showed that a common factor for the development of these variants was AZT (3\u2032-azido-3\u2032-deoxythymidine, zidovudine) therapy in combination with 2\u2032,3\u2032-dideoxyinosine or 2\u2032,3\u2032-dideoxycytidine, although treatment patterns varied considerably. Site-directed mutagenesis studies confirmed that 69Ser-(Ser-Ser) in an AZT resistance mutational background conferred simultaneous resistance to multiple nucleoside analogs. The insertions are located in the \u201cfingers\u201d domain of RT. Modelling the 69Ser-(Ser-Ser) insertion into the RT structure demonstrated the profound direct effect that this change is likely to have in the nucleoside triphosphate binding site of the enzyme. Our data highlight the increasing problem of HIV-1 multidrug resistance and underline the importance of continued resistance surveillance with appropriate, sufficiently versatile genotyping technology and phenotypic drug susceptibility analysis.<\/jats:p>","DOI":"10.1128\/aac.43.8.1961","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:35:20Z","timestamp":1539045320000},"page":"1961-1967","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":140,"title":["A Family of Insertion Mutations between Codons 67 and 70 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Multinucleoside Analog Resistance"],"prefix":"10.1128","volume":"43","author":[{"given":"B. A.","family":"Larder","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Virco UK, Ltd., Cambridge, CB4 4GH,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bloor","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Virco UK, Ltd., Cambridge, CB4 4GH,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. D.","family":"Kemp","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Virco UK, Ltd., Cambridge, CB4 4GH,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Hertogs","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Virco N.V., B-2800, Mechelen, Belgium2; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. L.","family":"Desmet","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Virco N.V., B-2800, Mechelen, Belgium2; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Miller","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Goethe Universita\u0308t, Frankfurt, Germany3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sturmer","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Goethe Universita\u0308t, Frankfurt, Germany3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Staszewski","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Goethe Universita\u0308t, Frankfurt, Germany3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ren","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Laboratory of Molecular Biophysics, University of Oxford, Oxford, OX1 3QU,4 United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. K.","family":"Stammers","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Laboratory of Molecular Biophysics, University of Oxford, Oxford, OX1 3QU,4 United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. I.","family":"Stuart","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Laboratory of Molecular Biophysics, University of Oxford, Oxford, OX1 3QU,4 United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pauwels","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Virco N.V., B-2800, Mechelen, Belgium2; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"Bloor S. K. Hertogs R. L. Desmet R. Pauwels and B. A. Larder. 1998. Virological basis for HIV-1 resistance to stavudine investigated in clinical samples. International Workshop on HIV Drug Resistance and Treatment Strategies 24\u201327 June 1998 Lake Maggiore Italy. Antivir. Ther. 3 (Suppl. 2) abstract 15."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.10.2231"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1128\/jvi.70.12.8270-8276.1996","article-title":"Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor.","volume":"70","author":"Condra J. H.","year":"1997","unstructured":"Condra J. H. Holder D. J. Shleiff W. A. Blahy O. M. Danovich R. M. Gabryelski L. J. Graham D. J. Laird D. Quintero J. Rhodes A. Robbins H. Roth E. Shivaprakash M. Yang T. Chodakewitz J. A. Deutsch P. J. Leavitt R. Y. Massari F. E. Mellors J. W. Squires K. E. Steigbigel R. T. Teppler H. Emini E. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J. Virol. 70 1997 8270 8276","journal-title":"J. Virol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-6-199503150-00001"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/516511"},{"key":"e_1_3_2_7_2","unstructured":"de Jong J. J. S. Jurriaans J. Goudsmit E. Baan R. Huismans S. Danner M. Hillebrand J. H. ten Veen and F. de Wolf. 1998. Insertion of two amino acids in reverse transcriptase (RT) during antiretroviral combination therapy: implications for resistance against nucleoside RT inhibitors. International Workshop on HIV Drug Resistance and Treatment Strategies 24\u201327 June 1998 Lake Maggiore Italy. Antivir. Ther. 3 (Suppl. 2) abstract 18."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2992081"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.9.5930-5934.1996"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.2.269"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.24.1984"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.11.8010-8018.1996"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5394.1669"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.2.1086-1090.1996"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(85)15014-7"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0108767390010224"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.5.1934"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-2-341"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.6.5093-5098.1998"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1074\/jbc.273.13.7529","article-title":"Insertions into the \u03b23-\u03b24 hairpin loop of HIV-1 reverse transcriptase reveal a role for the fingers subdomain in processive polymerization.","volume":"273","author":"Kew Y.","year":"1998","unstructured":"Kew Y. Olsen L. R. Japour A. J. Prasad V. R. Insertions into the \u03b23-\u03b24 hairpin loop of HIV-1 reverse transcriptase reveal a role for the fingers subdomain in processive polymerization. J. Biol. Chem. 273 1998 7529 7537","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0796-753"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00002030-199612005-00005","article-title":"Clinical significance of drug resistance in HIV-1 infection.","volume":"10","author":"Kuritzkes D. R.","year":"1996","unstructured":"Kuritzkes D. R. Clinical significance of drug resistance in HIV-1 infection. AIDS 10 (Suppl. 5) 1996 S27 S31","journal-title":"AIDS"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.6.1428"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2479983"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/365451a0"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7542804"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/365671a0"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.5.1157"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/515304"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1086\/514056"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1073\/pnas.95.16.9518","article-title":"3\u2032-Azido-3\u2032-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes.","volume":"95","author":"Ren J.","year":"1998","unstructured":"Ren J. Esnouf R. M. Hopkins A. L. Jones E. Y. Kirby I. Keeling J. Ross C. K. Larder B. A. Stuart D. I. Stammers D. K. 3\u2032-Azido-3\u2032-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes. Proc. Natl. Acad. Sci. USA 95 1998 9518 9523","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_33_2","first-page":"129","article-title":"Mutations in retroviral genes associated with drug resistance.","volume":"5","author":"Schinazi R. F.","year":"1997","unstructured":"Schinazi R. F. Larder B. A. Mellors J. W. Mutations in retroviral genes associated with drug resistance. Int. Antivir. News 5 1997 129 142","journal-title":"Int. Antivir. News"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.6.2398"},{"key":"e_1_3_2_35_2","first-page":"696","article-title":"Lack of emergence of genotypic resistance to stavudine after two years of monotherapy.","volume":"11","author":"Soriano V.","year":"1997","unstructured":"Soriano V. Dietrich U. Villalba N. Immelmann A. Gil-Aguado A. Echevarria S. Clotet B. Ocana I. Santamaria J. M. Bouza E. Barona V. Gatell J. M. Gonzalez-Lahoz J. Lack of emergence of genotypic resistance to stavudine after two years of monotherapy. AIDS 11 1997 696 697","journal-title":"AIDS"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1716788"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.2.284"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.12.5653"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.8.2533-2537.1999"},{"key":"e_1_3_2_40_2","unstructured":"Whitcomb J. M. K. Limoli T. Wrin D. Smith H. Tian N. Parkin Y. S. Lie and C. J. Petropoulos. 1998. Phenotypic and genetic analysis of stavudine-resistant isolates of HIV-1. International Workshop on HIV Drug Resistance and Treatment Strategies 24\u201327 June 1998 Lake Maggiore Italy. Antivir. Ther. 3 (Suppl. 2) abstract 17."},{"key":"e_1_3_2_41_2","unstructured":"Winters M. A. K. I. Coolley Y. A. Girard D. J. Levee H. Hamdan D. A. Katzenstein R. W. Shafer and T. C. Merigan. 1998. Phenotypic and molecular analysis of HIV-1 isolates possessing 6 bp inserts in the reverse transcriptase gene that confer resistance to nucleoside analogues. International Workshop on HIV Drug Resistance and Treatment Strategies 24\u201327 June 1998 Lake Maggiore Italy. Antivir. Ther. 3 (Suppl. 2) abstract 16."},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1172\/JCI4948","article-title":"A 6-base pair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside analogues.","volume":"102","author":"Winters M. A.","year":"1998","unstructured":"Winters M. A. Coolley K. I. Girard Y. A. Levee D. J. Hamdan H. Shafer R. W. Katzenstein D. A. Merigan T. C. A 6-base pair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside analogues. J. Clin. Investig. 102 1998 1769 1775","journal-title":"J. Clin. Investig."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.8.1961","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.8.1961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:23:05Z","timestamp":1645460585000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.43.8.1961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["10.1128\/AAC.43.8.1961"],"URL":"https:\/\/doi.org\/10.1128\/aac.43.8.1961","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,8]]},"assertion":[{"value":"1999-02-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-05-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}